Company intelligence / Profile preview

IDTD Consulting

USA

Ownership: Private
Development stage: Other

Overview

IDTD Consulting, also known as Infectious Disease Technology Development Consulting, is a specialized strategic advisory firm led by Dr. Matthew A. Wikler. The company provides comprehensive clinical, medical, and regulatory guidance to biotechnology and pharmaceutical firms developing novel technologies for the prevention and treatment of infectious diseases. Leveraging Dr. Wikler's extensive experience as a former FDA Deputy Director and senior industry executive, IDTD Consulting assists clients in navigating complex development pathways and regulatory requirements. The firm's expertise spans a wide range of anti-infective programs, including antibacterials, antifungals, and antivirals.

Therapeutic areas: Infectious Diseases
Industry: Consulting

Partnerships

Matinas BioPharmaClinical and Laboratory Standards Institute (CLSI)

Beyond the preview

Go deeper on IDTD Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDTD Consulting.

Explore the full profile